New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Werewolf Therapeutics, Inc.
HOWL
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

50M

Biotechnology

Next Earning date - 02 May 2025

50M

Biotechnology

Next Earning date - 02 May 2025

1.12USD

Shape-0.01 ( -0.88%)
moonAfter-hours 1.42$arrow-right-up0.02 (1.43%)
Market Closed (as of Mar 24, 20:00 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-13%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

84%

Quote Panel

Shape
Updated March 24, 2025
1W -3.45 % 1M -12.50 % 3M -29.56 % 1Y -81.36 %

Key Metrics

Shape
  • Market Cap

    50.21M


  • Shares Outstanding

    44.83M


  • Share in Float

    33.13M


  • Dividende

    0


  • Earning Date

    02 May 2025


  • Price Target

    1.12


  • Average Volume

    272658


  • Beta

    0.378


  • Range

    1.03-6.89


  • Industry

    Biotechnology


  • Website

    https://werewolftx.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

HOWL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3M

ShapeNaN%

2025-Revenue

$1.69

Shape-267%

2025-EPS

$504K

Shape97%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

JMP Securities

initialise

Previous: Market Outperform

2024-04-03

Now: Outperform

JMP Securities

initialise

Previous: Not converted

2024-04-03

Now: Market Outperform

Wedbush

initialise

Previous: Not converted

2023-08-24

Now: Outperform

Zacks Investment Research

upgrade

Previous: Not converted

2022-04-26

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.34
vs -0.56

Q2.23

arrow
arrow

N/A

-0.14
vs -0.53

Q3.23

arrow
arrow

N/A

-0.23
vs -0.40

Q4.23

arrow
arrow

N/A

-0.33
vs -0.39

Q1.24

arrow
arrow

N/A

-0.39
vs -0.34

Q2.24

arrow
arrow

N/A

-0.43
vs -0.14

Q3.24

arrow
arrow

N/A

-0.38
vs -0.23

Q4.24

arrow
arrow

N/A

-0.46
vs -0.33

Q1.25

arrow
arrow

N/A

-0.38
vs -0.39

Q2.25

arrow
arrow

N/A

-0.39
vs -0.43

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

4.5M  vs NA

Q2.23

arrow
arrow

+95%

8.1M  vs 4.1M

Q3.23

arrow
arrow

+19%

5.9M  vs 5M

Q4.23

arrow
arrow

-79%

1.5M  vs 7.3M

Q1.24

arrow
arrow

-83%

742K  vs 4.5M

Q2.24

arrow
arrow

-86%

1.1M  vs 8.1M

Q3.24

arrow
arrow

-100%

NA  vs 5.9M

Q4.24

arrow
arrow

-100%

NA  vs 1.5M

Q1.25

arrow
arrow

-60%

300K  vs 742K

Q2.25

arrow
arrow

-74%

300K  vs 1.1M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-9%

-0.09
vs -0.09

Q2.23

arrow
arrow

-4%

-0.04
vs -0.09

Q3.23

arrow
arrow

-7%

-0.07
vs -0.04

Q4.23

arrow
arrow

-11%

-0.11
vs -0.07

Q1.24

arrow
arrow

-14%

-0.14
vs -0.11

Q2.24

arrow
arrow

-17%

-0.17
vs -0.14

Q3.24

arrow
arrow

-19%

-0.19
vs -0.17

Q4.24

arrow
arrow

-28%

-0.28
vs -0.19

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

37

37
vs 39

-5%

Q2.23

arrow
arrow

36

36
vs 37

-3%

Q3.23

arrow
arrow

35

35
vs 36

-3%

Q4.23

arrow
arrow

43

43
vs 35

23%

Q1.24

arrow
arrow

63

63
vs 43

47%

Q2.24

arrow
arrow

73

73
vs 63

16%

Q3.24

arrow
arrow

70

70
vs 73

-4%

Q4.24

arrow
arrow

74

74
vs 70

6%

Earnings Growth

Latest News